Introduction
The advancement of neurotechnology and artificial intelligence necessitates a redefinition of the concept of human agency. Modern medicine no longer merely observes the brain; it actively preconfigures the mechanisms that construct our "Self."
In this article, we explore the theses presented in the book Our Brains Our Selves. You will learn how pharmacology, deep brain stimulation, and brain-computer interfaces are shifting the boundaries of autonomy and what authenticity means in an era of hybrid agency.
Neurotechnology as a Tool for Reconstructing Subjectivity
The author notes that neurochemical interventions can profoundly transform behavior. The case of a patient named David demonstrates that the drug ropinirole restored his social activity, yet in another individual, the same medication triggered pathological gambling.
Addressing the question of identity: technology does not always alter a person negatively. It can either diminish autonomy by introducing foreign values or enhance it by removing blocks that prevent the realization of one's own goals.
According to the author, it is crucial to distinguish between a change in personality and an improvement in quality of life. By definition, effective therapy changes a person, but the objective is to restore agency rather than create a new identity.
Authenticity as Motivational Alignment, Not Absence of Intervention
Do these interventions cause a patient to cease being themselves? The author argues that authenticity does not consist in the absence of intervention, but rather in the alignment of motivations. All our desires have biological or social causes.
The author references Harry Frankfurt's theory of first-order and second-order desires. That which is consistent with a person's reflective values is authentic. Therefore, a patient may perceive their post-treatment state as being "more themselves."
In this view, neurotechnology does not create an artificial "Self," but rather allows for the recovery of competencies that were functionally disconnected. The problem lies not in the cause of the change, but in whether the patient recognizes the new state as their own.
Adaptive Brain Stimulation and the Hybrid Agency Loop
Modern adaptive deep brain stimulation (aDBS) systems are transitioning from an open-loop model to a closed-loop regulatory system. The device interprets biological signals in real-time and corrects brain activity accordingly.
This creates a hybrid agency loop, where the boundary between therapy and the system regulating functioning becomes fluid. The ethical challenge here is defining the objective function—that is, determining which state of the brain we consider desirable.
The author warns that clinical optimization is not always synonymous with the best possible life for a given individual. There is a risk of value conflict when an algorithm strives to reduce symptoms at the expense of the patient's cognitive flexibility.
Summary
In a world where the line between biological impulse and algorithmic correction is blurred, we must ask whether we are trading freedom of choice for the comfort of being steered.
The author sheds light on the paradox of modern neurotechnology: in striving to restore agency, we may create systems in which the notion of the "author" of a decision becomes an illusion.
Ultimately, we face the question of whether we are prepared to accept a version of ourselves that is the result of statistical optimization rather than organic struggle and error.
Frequently Asked Questions
Does brain intervention using drugs and technology change human identity, or rather help a person recover their true self?
Brain intervention can both change identity and help in recovering one's true self; therefore, opposing treatment to a change in person is too simplistic. This technology limits autonomy when it induces behaviors alien to the patient's values, but increases it if it removes pathological mechanisms that prevent the realization of one's own goals.
Do neurotechnological and pharmacological interventions make a patient cease to be themselves?
These interventions do not necessarily make the patient cease to be themselves, as they may even increase autonomy by restoring the ability to achieve one's own goals. The key is the relationship between the new state and the person's values and history, as well as their ability to recognize it as their own; research on DBS indicates that permanent negative personality changes are rare.
In what way do modern brain stimulation systems change the relationship between the patient and technology, and what ethical challenges are associated with this?
Modern adaptive systems change the relationship with the patient by creating a hybrid loop of agency, in which the device interprets biological signals in real time and participates in the continuous regulation of the organism's functioning. This is associated with ethical challenges regarding the definition of the algorithm's objective function and conflicts of values, as the technical optimization of clinical parameters is not always identical to quality of life and individual patient needs.
How do brain-computer interfaces affect the authorship of utterances, and who bears responsibility for errors in the algorithmic reconstruction of intention?
BCI interfaces affect the authorship of utterances by using language models to complete imperfect neuronal signals, which blurs the line between the user's intention and the algorithm's suggestion. Responsibility for errors in intent reconstruction is linked to the necessity of providing the user with real corrective control, allowing them to accept, correct, or veto the generated message.
How do human responsibility and privacy change in a world of bidirectional brain-computer interfaces?
Responsibility changes into a structure of interdependent authorship, where it is distributed among participants depending on their ability to control and correct the system. Privacy evolves toward the protection of mental integrity and inferential privacy, guarding against unauthorized interference in mental processes and the drawing of statistical conclusions from neurodata by algorithms.
Where is the line between treatment and human enhancement, and what are the social consequences of neuroenhancement?
The boundary between treatment and enhancement does not depend solely on biological mechanisms, but on the goal, clinical context, risk, and social significance of the intervention. The social consequences of neuroenhancement include the risk of deepening inequalities in access to cognitive abilities and the emergence of pressure to enhance oneself, which may lead to a situation resembling an arms race.
How does the use of generative AI affect my autonomy and decision-making process?
The use of generative AI can lead to a blurring of the line between one's own cognitive processes and external support, making it difficult to monitor the origin of information. This system can act as an architect of the decision space, influencing user autonomy through the selection of presented options and arguments, as well as the way they are presented.
